Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating docetaxel and cisplatin in stage III/IV non-small cell lung cancer was terminated with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating hydroxychloroquine with carboplatin, paclitaxel, and bevacizumab in recurrent advanced non-small cell lung cancer…
-
CLINICAL_TRIALS research · 2013-11-21Clinical Trial Update: Study of Use of CTC in NSCLC
A clinical trial update from the University of Virginia regarding the use of circulating tumor cells (CTCs) in Non-Small Cell Lung Cancer, w…
-
CLINICAL_TRIALS withdrawal · 2013-11-21Clinical Trial Update: Immune Response and Safety of HS110 Vaccine in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial of HS110 vaccine in combination with Erlotinib for non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of gemcitabine plus paclitaxel in advanced non-small cell lung cancer and other solid…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation [Phase 3]
Phase 3 trial comparing afatinib (BIBW 2992) to chemotherapy as first-line treatment in EGFR-mutant non-small cell lung cancer has completed…
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update reports on radiation therapy for patients with non-small cell lung cancer across Phase 1 and Phase 2, and notes t…
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: Nodal Upstaging in VATS Anatomical Resections for NSCLC
This clinical trial update discusses nodal upstaging observed during VATS anatomical resections for non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2013-11-14Clinical Trial Update: Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC) [Phase 1, Phase 2]
This clinical trial update concerns a Phase 1/2 study evaluating the combination of vorinostat and gefitinib in relapsed or refractory advan…
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC) [Phase 1]
Phase 1 dose-escalation study of BAY43-9006 (sorafenib) in combination with carboplatin, paclitaxel, and bevacizumab in patients with untrea…
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib [Phase 2]
Phase I/II trial updates show results for afatinib (BIBW 2992) in advanced non-small cell lung cancer, including patients who progressed aft…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC [Phase 2]
Phase 2 clinical trial evaluating preoperative chemotherapy with bevacizumab in select stages of non-small cell lung cancer was terminated w…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of Triapine (3-AP) and gemcitabine for metastatic non-small cell lung cancer has complet…
-
CLINICAL_TRIALS research · 2013-11-06Clinical Trial Update: Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression [Phase 3]
A Phase 3 trial evaluating the combination of gossypol with docetaxel and cisplatin in advanced non-small cell lung cancer with high APE1 ex…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A clinical trial update noting the completion of a Phase 1/2 study of ABI-007 (nab-paclitaxel) in chemotherapy-naïve patients with stage IV …
-
CLINICAL_TRIALS research · 2013-11-06Clinical Trial Update: Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer [Phase 2]
This document reports a Phase 2 clinical trial update of a biological therapy in patients with non-small cell lung cancer who have previousl…
-
CLINICAL_TRIALS research · 2013-11-06Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [Phase 2]
The document reports an Epimmune-sponsored Phase 2 trial of a vaccine therapy for stage IIIB, stage IV, or recurrent non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2013-11-05Clinical Trial Update: Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLC [Phase 2, Phase 3]
Phase 2 and Phase 3 clinical trials evaluating EVOZAC Calming Skin Spray to prevent EGFR-TKI–associated rash in non-small cell lung cancer h…
-
CLINICAL_TRIALS trial_result · 2013-11-04Clinical Trial Update: Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer [Phase 1]
A Phase 1 clinical trial evaluates the combination of metronomic oral vinorelbine and sorafenib in adults with advanced non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Radiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung Cancer [Phase 1]
Update on a Phase 1 trial evaluating 3-Dimensional treatment planning-based radiation therapy for patients with non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating motexafin gadolinium in combination with pemetrexed for second-line non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2013-10-30Clinical Trial Update: Retrospective Study in a NSCLC M+ p
This document reports a completed retrospective study in patients with EGFR-mutated non-small cell lung cancer, sponsored by AstraZeneca.
-
CLINICAL_TRIALS trial_result · 2013-10-30Clinical Trial Update: Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer [Phase 1]
Phase 1 study of Pazopanib plus Vinorelbine in metastatic non-small cell lung cancer and metastatic breast cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-10-28Clinical Trial Update: Feasibility of Exercise With Post-Op Lung Cancer Patients [NA]
A completed feasibility study from Duke University evaluating whether exercise interventions can be implemented with patients after surgery …
-
CLINICAL_TRIALS research · 2013-10-28Clinical Trial Update: Epidemiological and Scientific Evaluation of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or m
This clinical trial update provides an epidemiological and scientific evaluation of EGFR mutation status in patients with newly diagnosed lo…